Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in OTLK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$27,621
-$244,173 QoQ
Shares Held
134,084
-22.1% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 54 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in OTLK Over Time

Shares Held

Position Value (USD)

Derivatives in OTLK

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$8,816
PutShares
42,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. OTLK ranks #336 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OTLK

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $27,621 134,084
2026-03-31 $8,816 42,800
2025-12-31 $304,782 192,900
2025-12-31 $271,794 172,022
2025-12-31 $581,124 367,800
2025-09-30 $25,970 24,500
2025-09-30 $224,106 211,421
2025-06-30 $188,430 117,769
2025-06-30 $26,880 16,800
2025-03-31 $21,228 17,400
2025-03-31 $86,524 70,922
2024-12-31 $153,609 81,275
2024-12-31 $40,068 21,200
2024-09-30 $225,348 42,200
2024-09-30 $60,876 11,400
2024-06-30 $115,703 15,678
2024-06-30 $96,678 13,100